Physician profile
Stacey Schellhammer
NPI 1760298657
$4,246.22
in general payments reported to CMS, 2019-2025
13 companies · $4,246 in 2025
The $4,246 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $4,246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,141 · Food and Beverage: $644 · Travel and Lodging: $461.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,141.00 |
| Food and Beverage | $643.92 |
| Travel and Lodging | $461.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $3,602.30 | 2025 | Arrow |
| Amgen INC. | $184.28 | 2025 | Repatha, Otezla |
| Novo Nordisk INC | $99.03 | 2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $67.74 | 2025 | Zepbound, Mounjaro |
| Pfizer INC. | $50.51 | 2025 | |
| Abbvie INC. | $48.52 | 2025 | |
| Glaxosmithkline, LLC. | $45.94 | 2025 | Trelegy Ellipta |
| Exact Sciences Corporation | $37.95 | 2025 | Cologuard Collection Kit |
| Baxter Healthcare | $29.48 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Astrazeneca Pharmaceuticals LP | $21.21 | 2025 | Farxiga |
| Medtronic, INC. | $20.65 | 2025 | Intellis Adaptivestim |
| Teva Pharmaceuticals USA, INC. | $20.14 | 2025 | Austedo Xr |
| Endo USA, INC. | $18.47 | 2025 | Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Schellhammer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.